Your browser doesn't support javascript.
loading
Cultural adaptation and validation of a peninsular Spanish version of the MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire). / Adaptación cultural y validación al español de España del MSTCQ© (Multiple Sclerosis Treatment Concerns Questionnaire).
Muntéis Olivas, E; Navarro Mascarell, G; Meca Lallana, J; Maestre Martínez, A; Pérez Sempere, Á; Gracia Gil, J; Pato Pato, A.
Afiliación
  • Muntéis Olivas E; Hospital del Mar, Barcelona, España. Electronic address: emunteis@parcdesalutmar.cat.
  • Navarro Mascarell G; Hospital Virgen de la Macarena, Sevilla, España.
  • Meca Lallana J; Unidad de Esclerosis Múltiple, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, España; Cátedra de Neuroinmunología Clínica y Esclerosis Múltiple, UCAM Universidad Católica San Antonio de Murcia, Murcia, España.
  • Maestre Martínez A; Hospital de Jaén, Jaén, España.
  • Pérez Sempere Á; Hospital General de Alicante, Alicante, España.
  • Gracia Gil J; Hospital de Albacete, Albacete, España.
  • Pato Pato A; Hospital Povisa, Vigo, Pontevedra, España.
Neurologia ; 32(1): 29-39, 2017.
Article en En, Es | MEDLINE | ID: mdl-25697827
ABSTRACT

INTRODUCTION:

Although subcutaneous treatments for multiple sclerosis (MS) have been shown to be effective, adverse reactions and pain may adversely affect treatment satisfaction and adherence. This study presents an adapted and validated Spanish version of the Multiple Sclerosis Treatment Concerns Questionnaire© (MSTCQ), which evaluates satisfaction with the injection device (ID) across 4 domains injection system (A), side effects (B) (flu-like symptoms, reactions, and satisfaction), experience with treatment (C) and benefits (D).

METHODS:

Two study phases 1) Cultural adaptation process with input from experts (n=6) and patients (n=30). 2) Validation obtained by means of an observational, cross-sectional, multi-centre study evaluating 143 adult MS patients using an ID. Tools employed MSTCQ©, Patient-Reported Indices for Multiple Sclerosis (PRIMUS©), and Treatment Satisfaction Questionnaire for Medication (TSQM©). Psychometric properties Feasibility (percentage of valid cases and floor/ceiling effects); Reliability (Cronbach α) and test-retest correlation (n=41, intraclass correlation coefficient, ICC); and construct validity (factor analysis of domains A and B) and convergent validity (Spearman rank-order correlation for MSTCQ© vs TSQM©).

RESULTS:

Mean age (SD) was 41.94 (10.47) years, 63% of the group were women, and 88.11% presented relapsing-remitting MS. Mean (SD) EDSS score was 2.68 (1.82) points. MSTCQ© completion was high (0%-2.80% missing data). Internal consistency was high at α=0.89 for the total score (A+B) and α=0.76, 0.89, and 0.92 for domains A, B, and C, respectively. The version demonstrated excellent test-retest reliability for the total (ICC=0.98) and for domains A, B, and C ICC=0.82, 0.97, and 0.89, respectively. Factor analysis corroborated the internal structure of the original questionnaire. The association between total and domain scores on both the MSTCQ© and the TSQM© was moderately strong (Rho=0.42-0.74) and significant (P<.05 and P<.01).

CONCLUSION:

The Spanish version of MSTCQ© demonstrates appropriate psychometric properties.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psicometría / Encuestas y Cuestionarios / Características Culturales / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En / Es Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Psicometría / Encuestas y Cuestionarios / Características Culturales / Esclerosis Múltiple Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En / Es Año: 2017 Tipo del documento: Article